A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.
PHASE1CompletedINTERVENTIONAL
Enrollment
64
Participants
Timeline
Start Date
Not specified
Study Completion Date
April 30, 1990
Conditions
HIV Infections
Interventions
DRUG
Zalcitabine
Trial Locations (1)
331361013
Univ. of Miami AIDS CRS, Miami
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000704 - A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC. | Biotech Hunter | Biotech Hunter